Harari, Paul M.

Understanding resistance to EGFR inhibitors—impact on future treatment strategies

Wheeler, D. L., Dunn, E. F., & Harari, P. M. (2010) · Nature Reviews Clinical Oncology

HER2/EGFR in Cancer ResearchLung Cancer Treatments and Mutations

Cited by 683

Mechanisms of acquired resistance to cetuximab: role of HER (ErbB) family members

Wheeler, D. L., Huang, S., Kruser, T. J., Nechrebecki, M. M., Armstrong, E. A., Benavente, S., Gondi, V, Hsu, K.-T., & Harari, P. M. (2008) · Oncogene

HER2/EGFR in Cancer ResearchLung Cancer Treatments and Mutations

Cited by 550

Epidermal growth factor receptor inhibition strategies in oncology

Harari, P. M. (2004) · Endocrine-Related Cancer

HER2/EGFR in Cancer ResearchLung Cancer Treatments and Mutations

Cited by 423

Biology of Interactions: Antiepidermal Growth Factor Receptor Agents

Harari, P. M., Allen, G. W., & Bonner, J. A. (2007) · Journal of Clinical Oncology

HER2/EGFR in Cancer ResearchLung Cancer Treatments and Mutations

Cited by 214

Epidermal Growth Factor Receptor cooperates with Src Family Kinases in acquired resistance to cetuximab

Wheeler, D. L., Iida, M., Kruser, T. J., Nechrebecki, M. M., Dunn, E. F., Armstrong, E. A., Huang, S., & Harari, P. M. (2009) · Cancer Biology & Therapy

HER2/EGFR in Cancer ResearchLung Cancer Treatments and Mutations

Cited by 157

Human organotypic lymphatic vessel model elucidates microenvironment-dependent signaling and barrier function

Gong, M. M., Lugo-Cintron, K. M., White, B. R., Kerr, S. C., Harari, P. M., & Beebe, D. J. (2019) · Biomaterials

Lymphatic System and DiseasesLymphatic Disorders and Treatments

Cited by 87

Small-molecule inhibition of MDM2-p53 interaction augments radiation response in human tumors

Werner, L. R., Huang, S., Francis, D. M., Armstrong, E. A., Ma, F., Li, C., Iyer, G., Canon, J., & Harari, P. M. (2015) · Molecular Cancer Therapeutics

Cancer-related Molecular PathwaysDNA Repair Mechanisms

Cited by 45

Microphysiological head and neck cancer model identifies novel role of lymphatically secreted monocyte migration inhibitory factor in cancer cell migration and metabolism

Yada, R. C., Desa, D. E., Gillette, A. A., Bartels, E., Harari, P. M., Skala, M. C., Beebe, D. J., & Kerr, S. C. (2023) · Biomaterials

Macrophage Migration Inhibitory FactorLymphatic System and Diseases

Cited by 30